Cavers Greg
Chief Financial Officer
PurchaseAlert
- Shares
- 3,000
- Price
- $12.91
- Value
- $38,730
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•21 filings
HELP
Helus Pharma Inc.
Net purchases of $9.7M over the last 3 months
4 buyers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 2 CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
+$9,670,162
4 buyers · 0 sellers
12-month purchases
$9,670,162
4 distinct insiders
12-month sales
$0.00
0 distinct insiders
Highlighted alerts
9
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
2 executive purchases found
Get HELP insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
HELP overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
11
Raw transactions
Everything returned by the filing
9
Voluntary view
P/S trades after deterministic checks
2
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 248,000
- Price
- —
- Footnotes
- 2
Represents grant of 248,000 restricted stock units ("RSUs") on September 30, 2026, with immediate vesting. Each RSU represents a right to receive one share of the Issuer's common stock.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Halstead Michael
Chief Executive Officer
PurchaseAlert
- Shares
- 100,000
- Price
- $13.47
- Value
- $1,347,050
Glavine Paul
Chief Growth Officer
PurchaseAlert
- Shares
- 100,000
- Price
- $12.47
- Value
- $1,247,190
Glavine Paul
Chief Growth Officer
PurchaseAlert
- Shares
- 100,000
- Price
- $12.47
- Value
- $1,247,190
So Eric H. L.
Executive Chair
PurchaseAlert
- Shares
- 100,000
- Price
- $12.39
- Value
- $1,238,670
So Eric H. L.
Executive Chair
PurchaseAlert
- Shares
- 100,000
- Price
- $12.09
- Value
- $1,208,900
Glavine Paul
Chief Growth Officer
PurchaseAlert
- Shares
- 100,000
- Price
- $11.78
- Value
- $1,178,280
So Eric H. L.
Executive Chair
PurchaseAlert
- Shares
- 95,000
- Price
- $11.81
- Value
- $1,121,475
Glavine Paul
Chief Growth Officer
PurchaseAlert
- Shares
- 90,000
- Price
- $11.59
- Value
- $1,042,677
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 29, 2026 | Cavers Greg Chief Financial Officer | Purchase | 3,000 | $12.91 | $38,730 | |
| Sep 21, 2026 | Halstead Michael Chief Executive Officer | Purchase | 100,000 | $13.47 | $1,347,050 | |
| Sep 08, 2026 | Glavine Paul Chief Growth Officer | Purchase | 100,000 | $12.47 | $1,247,190 | |
| Sep 08, 2026 | Glavine Paul Chief Growth Officer | Purchase | 100,000 | $12.47 | $1,247,190 | |
| Sep 08, 2026 | So Eric H. L. Executive Chair | Purchase | 100,000 | $12.39 | $1,238,670 | |
| Sep 04, 2026 | So Eric H. L. Executive Chair | Purchase | 100,000 | $12.09 | $1,208,900 | |
| Sep 03, 2026 | Glavine Paul Chief Growth Officer | Purchase | 100,000 | $11.78 | $1,178,280 | |
| Sep 01, 2026 | So Eric H. L. Executive Chair | Purchase | 95,000 | $11.81 | $1,121,475 | |
| Aug 31, 2026 | Glavine Paul Chief Growth Officer | Purchase | 90,000 | $11.59 | $1,042,677 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.